Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome

Neurosurgery

Volumn 50, Issue 3, 2002, Pages 544-549

  Soriano, Sulpicio G ^a   Cowan, Douglas B ^a   Proctor, Mark R ^a   Scott, R Michael ^a   Loizer, Alan P ^b   Sutton, Leslie N ^b   Selman, Warren R ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Children's Hospital ^*

Author keywords

Cerebral ischemia; E selectin; Intercellular adhesion molecule Type 1; Moyamoya syndrome; Stroke

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; SERUM ALBUMIN; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ANGIOGRAPHY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOYAMOYA DISEASE; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; SPINE MALFORMATION;

ARNOLD-CHIARI MALFORMATION; CHILD; CHILD, PRESCHOOL; E-SELECTIN; FEMALE; HUMANS; INFANT; INTERCELLULAR ADHESION MOLECULE-1; MALE; MOYAMOYA DISEASE; NEURAL TUBE DEFECTS; OSMOLAR CONCENTRATION; SERUM ALBUMIN; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036523938     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200203000-00022     Document Type: Article

References (35)

1. Adelson PD, Scott RM: Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg 23:26-33, 1995.
2. Birdsall HH, Lane C, Ramser MN, Anderson DC: Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence. J Immunol 148:2717-2723, 1992.
3. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P: A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 29:2129-2135, 1998.
4. Chen H, Chopp M, Zhang RL, Bodzin G, Chen Q, Rusche JR, Todd RF: Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia. Ann Neurol 35:458-463, 1994.
5. Clark RS, Carlos TM, Schiding JK, Bree M, Fireman LA, DeKosky ST, Kochanek PM: Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats. J Neurotrauma 13:333-341, 1996.
6. Cybulski MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791, 1991.
7. Frijns CJM, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R: Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28:2214-2218, 1997.
8. Gho YS, Kleinman HK, Sosne G: Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res 59:5128-5132, 1999.
9. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, Obrenovitch TP, Contreras TJ: Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17:246-253, 1985.
10. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Kikuchi H, Hashimoto N: A cerebrospinal fluid protein associated with moyamoya disease: Report of three cases. Neurosurgery 45:170-173, 1999.
11. 1 in the pathogenesis of moyamoya disease. J Neurosurg 89:623-629, 1995.
12. Kuroiwa T, Shibutani M, Okeda R: Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia. Acta Neuropathol (Berl) 76:62-70, 1988.
13. Kuroiwa T, Shibutani M, Okeda R: Nonhyperemic blood flow restoration and brain edema in experimental focal cerebral ischemia. J Neurosurg 70:73-80, 1989.
14. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM: Elevation of cerebrovascular fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 27:182-189, 1998.
15. Masuda J, Ogata J, Yutani C: Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24:1960-1967, 1993.
16. McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA: Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis. J Neuroimmunol 85:186-192, 1998.
17. Mocco J, Choudhri TF, Mack WJ, Laufer I, Lee J, Kiss S, Poisik A, Quest DO, Solomon RA, Connolly ES: Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery 48:718-721, 2001.
18. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996.
19. Polin RS, Bavek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, Lee KS: Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89:559-567, 1998.
20. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Teidy RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140:665-673, 1992.
21. Rieckmann P, Altenhofen B, Riegel A, Baudewig J, Felgenhauer K: Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann Neurol 41:326-333, 1997.
22. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K: Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci Lett 186:61-64, 1995.
23. Schliep G, Felgenhauer K: Serum-CSF protein gradients, the blood-CSF barrier and the local immune response. J Neurol 218: 77-96, 1978.
24. Silverman LM, Christenson RH: Determination of albumin with bromcresol green, in Burtes CA, Ashwood ER (eds): Tietz Textbook of Clinical Chemistry. Philadelphia, W.B. Saunders Co., 1994, ed 2, pp 702-704.
25. Silverman LM, Christenson RH: Proteins in cerebrospinal fluid, in Burtes CA, Ashwood ER (eds): Tietz Textbook of Clinical Chemistry. Philadelphia, W.B. Saunders Co., 1994, ed 2, pp 723-726.
26. Soriano SG, Coxon A, Wang YF, Frosch MP, Lipton SA, Hickey PR, Mayadas TN: Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 30:134-139, 1999.
27. Soriano SG, Lipton SA, Wang YF, Xiao M, Springer TA, Gutierrez-Ramos JC, Hickey PR: Intercellular adhesion molecule-1 (ICAM-1) deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol 39:295-301, 1996.
28. Soriano SG, Sethna NF, Scott RM: Anesthetic management of children with moyamoya syndrome. Anesth Analg 77:1066-1070, 1993.
29. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57:827- 872, 1995.
30. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease: Disease showing abnormal net-like vessels in the base of brain. Arch Neurol 20:288-299, 1969.
31. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H: The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett 160:214-216, 1993.
32. Werner A, Kloss CU, Walter J, Kreutzberg GW, Raivich G: Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration. J Neurocytol 27:219-232, 1998.
33. Whalen MJ, Carlos TM, Kochanek PM, Wisniewski SR, Bell MJ, Carcillo JA, Clark RS, DeKosky ST, Adelson PD: Soluble adhesion molecules in CSF are increased in children with severe head injury. J Neurotrauma 15:777-787, 1998.
34. 2 production by interleukin-1β in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 12:912-918, 1999.
35. Yoshimoto T, Houkin K, Takahashi A, Abe H: Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease. Clin Neurol Neurosurg 99[Suppl 2]:S218-S220, 1997.